Product Details for: Padcev
RETURN TO SEARCH RESULTS
PRODUCT LABEL
Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
For Injection
Intravenous
20MG
Single-Dose Vial
351(a)
Padcev
Rx
002
For Injection
Intravenous
30MG
Single-Dose Vial
351(a)
Padcev
Rx
Proper Name
enfortumab vedotin-ejfv
enfortumab vedotin-ejfv
BLA Number
761137
761137
Applicant
Astellas Pharma US, Inc.
Astellas Pharma US, Inc.
Original Approval Date
December 18, 2019
December 18, 2019
Date of First Licensure